Search Within

Michael Andrew Postow

Formats
  1. Journal Article (191)
  2. Meeting Abstract (137)
  3. Editorial (9)
  4. Review (9)
  5. Book Section (4)
  6. Guidelines (4)
  7. Research Letter (4)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Department of Medicine (362)
  2. Melanoma Disease Management Team (362)
  3. Melanoma and Immunotherapeutics Service (362)
  4. Solid Tumor Oncology Division (362)
  5. GSK Faculty (178)
  6. Hematologic Malignancies, Division of (103)

More Groups

People
  1. Jedd Wolchok (158)
  2. Margaret Callahan (95)
  3. Katherine Panageas (64)
  4. Alexander Shoushtari (63)
  5. Paul Chapman (54)
  6. Parisa Momtaz (36)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (23)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Journal for ImmunoTherapy of Cancer (34)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (13)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. The Oncologist (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Biomed Central Ltd (43)
  3. Oxford University Press (32)
  4. Elsevier Inc. (31)
  5. American Association for Cancer Research (24)
  6. Wiley Blackwell (21)

More Publishers

Results (362)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toxicities of checkpoint inhibitors: Causes and management [interview]
    Journal Article

    Postow, M. A.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Myocarditis surveillance in patients with advanced melanoma on combination immune checkpoint inhibitor therapy: The Memorial Sloan Kettering Cancer Center experience
    Research Letter

    Lee Chuy, K.; Oikonomou, E. K.; Postow, M. A.; Callahan, M. K.; Chapman, P. B.; Shoushtari, A. N.; Neilan, T. G.; Fradley, M. G.; Ramanathan, L. V.; Wolchok, J. D.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Rational design of anti-GITR-based combination immunotherapy
    Journal Article

    Zappasodi, R.; Sirard, C.; Li, Y.; Budhu, S.; Abu-Akeel, M.; Liu, C.; Yang, X.; Zhong, H.; Newman, W.; Qi, J.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Evaluation of the response of unresectable primary cutaneous melanoma to immunotherapy visualized with reflectance confocal microscopy: A report of 2 cases
    Journal Article

    Navarrete-Dechent, C.; Cordova, M.; Postow, M. A.; Pulitzer, M.; Lezcano, C.; Halpern, A. C.; Rossi, A. M.
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer statement
    Guidelines

    Tsimberidou, A. M.; Levit, L. A.; Schilsky, R. L.; Averbuch, S. D.; Chen, D.; Kirkwood, J. M.; McShane, L. M.; Sharon, E.; Mileham, K. F.; Postow, M. A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial
    Journal Article

    Chung, D. J.; Carvajal, R. D.; Postow, M. A.; Sharma, S.; Pronschinske, K. B.; Shyer, J. A.; Singh-Kandah, S.; Dickson, M. A.; D'Angelo, S. P.; Wolchok, J. D.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors
    Meeting Abstract

    Sullivan, R. J.; Hong, D. S.; Tolcher, A. W.; Patnaik, A.; Shapiro, G.; Chmielowski, B.; Ribas, A.; Brail, L. H.; Roberts, J.; Lee, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutational burden, clinical features, and outcomes to PD-1 mono- and combination therapy in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Shoushtari, A. N.; Armenia, J.; Arora, A.; Rojas-Zamalloa, J.; Warner, A. B.; Derr, M.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Coit, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) + ipilimumab (ipi) + external beam radiotherapy (RT) in patients with metastatic melanoma
    Meeting Abstract

    Postow, M. A.; Knox, S. J.; Goldman, D.; Panageas, K.; Halpenny, D.; McCabe, D.; Macri, M. J.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save